A causal network analysis in an observational study identifies metabolomics pathways influencing plasma triglyceride levels

Metabolomics

Volumn 12, Issue 6, 2016, Pages

  Yazdani, Azam ^a   Yazdani, Akram ^a   Saniei, Ahmad ^b   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Causal network; Confounder; Direct effect; Genome DAG; Metabolomics; Triglyceride levels

Indexed keywords

ARACHIDONIC ACID; CARNITINE; GAMMA BUTYROBETAINE; GLUTAMIC ACID; GLYCINE; TRIACYLGLYCEROL;

ALGORITHM; ARTICLE; GAS CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; OBSERVATIONAL STUDY; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84971333790     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-016-1045-2     Document Type: Article

References (36)

1. Barabasi, A. L., & Oltvai, Z. N. (2004). Network biology: Understanding the cell’s functional organization. Nature Reviews Genetics, 5(2), 101–113.
2. Bartel, J., Krumsiek, J., & Theis, F. J. (2013). Statistical methods for the analysis of high-throughput metabolomics data. Computational and Structural Biotechnology Journal, 4(5), e201301009.
3. Barupal, D. K., et al. (2012). MetaMapp: Mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics, 13(1), 99.
4. Bell, F. P., & DeLucia, A. (1984). An inverse relationship between plasma carnitine and triglycerides in selected Macaca arctoides and Macaca nemistrina fed a low-fat chow diet. Comparative Biochemistry and Physiology Part B: Comparative Biochemistry, 78(2), 311–314.
5. Dawid A.P., (2007) Fundamentals of statistical causality. Research report 279, Department of statistical science, University College London.
6. Fontbonne, A., et al. (1989). Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia, 32(5), 300–304.
7. Fruhwirth, G. O., Loidl, A., Hermetter, A., et al. (2007). Oxidized phospholipids: From molecular properties to disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1772(7), 718–736.
8. Gao, J., et al. (2010). Metscape: A Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics, 26, 971–973.
9. German, J. B., et al. (2007). Lipidomics and lipid profiling in metabolomics. Current Opinion in Lipidology, 18(1), 66–71.
10. Gomez-Cabrero, D., et al. (2014). Data integration in the era of omics: Current and future challenges. BMC Systems Biology, 8(Suppl 2), I1.
11. Grapov, D., Wanichthanarak, K., & Fiehn, O. (2015). MetaMapR: Pathway independent metabolomic network analysis incorporating unknowns. Bioinformatics, 31(16):2757–2760. doi:10.1093/bioinformatics/btv194.
12. Hofmann, S. M., & Tschöp, M. H. (2009). Dietary sugars: A fat difference. The Journal of Clinical Investigation, 119(5), 1089.
13. Hokanson, J. E., & Austin, M. A. (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies. Journal of Cardiovascular Risk, 3(2), 213–219.
14. Inouye, M., Kettunen, J., Soininen, P., Silander, K., Ripatti, S., Kumpula, L. S., & Peltone, L. (2010). Metabonomic, transcriptomic, and genomic variation of a population cohort. Molecular Systems Biology, 6, 441.
15. Karnovsky, A., et al. (2012). Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics, 28, 373–380.
16. Krumsiek, J., Suhre, K., Illig, T., Adamski, J., & Theis, F. J. (2011). Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Systems Biology, 5, 21.
17. Künnert, B., et al. (1983). Metabolic triglyceride storage disorders. A report of 2 cases of systemic carnitine deficiency. Zentralblatt fur allgemeine Pathologie und pathologische Anatomie, 129(5), 413–422.
18. Nicholls, S. J., et al. (2011). Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: A randomized controlled trial. JAMA, 306(19), 2099–2109.
19. Patterson, A. D., et al. (2009). Human urinary metabolomic profile of PPARα induced fatty acid β-oxidation. Journal of Proteome Research, 8(9), 4293–4300.
20. Pearl, J. (2009). Causality: Models, reasoning, and inference. New York: Cambridge University Press.
21. Popkin, B. M., & Gordon-Larsen, P. (2004). The nutrition transition: Worldwide obesity dynamics and their determinants. International Journal of Obesity, 28, S2–S9.
22. Rubin, D. B. (2005). Causal inference using potential outcomes: Design, modeling, decisions. Journal of the American Statistical Association, 100, 322–331.
23. Schadt, Eric E., et al. (2005). An integrative genomics approach to infer causal associations between gene expression and disease. Nature Genetics, 37(7), 710–717.
24. The ARIC Investigators. (1989). The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. The ARIC investigators. American Journal of Epidemiology, 129(4), 687–702.
25. Vacha, Gian Maria, et al. (1983). Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: Decisive role of low levels of high-density lipoprotein-cholesterol. The American Journal of Clinical Nutrition, 38(4), 532–540.
26. Vidal, M., Cusick, M. E., & Barabasi, A. L. (2011). Interactome networks and human disease. Cell, 144(6), 986–998.
27. Voight, B. F., et al. (2012). Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study. The Lancet, 380(9841), 572–580.
28. Wang, L., et al. (2009). Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. Journal of Lipid Research, 50(2), 204–213.
29. Whelan, J., et al. (1995). Evidence that dietary arachidonic acid increases circulating triglycerides. Lipids, 30(5), 425–429.
30. Wijendran, V., et al. (2002). Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatric Research, 51(3), 265–272.
31. Yazdani, A. & Dunson D. B. (2015). A hybrid Bayesian approach for genome-wide association studies on related individuals. Bioinformatics, 31(24):3890-3896. doi:10.1093/bioinformatics/btv496.
32. Yazdani, A., & Boerwinkle, E. (2014). Causal inference at the population level. International Journal of Research in Medical Sciences, 2(4), 1368–1370.
33. Yazdani, A., & Boerwinkle, E. (2015). Causal inference in the age of decision medicine. Journal Data Mining Genomics Proteomics, 6(163), 2153–0602.
34. Yazdani, A., Yazdani, A., & Boerwinkle, E. (2016a). Conceptual aspects of causal networks in an applied context. Journal Data Mining Genomics Proteomics, 7, 188. doi:10.4172/2153-0602.1000188.
35. Yazdani, A., Yazdani, A., Samiei, A., & Boerwinkle, E. (2016b). Generating a robust statistical causal structure over 13 cardiovascular disease risk factors by data integration. Journal of Biomedical Informatics, 60, 114–119.
36. Zhu, J., Wiener, M., Zhang, C., Fridman, A., Minch, E., Lum, P., et al. (2007). Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations. PLoS Computational Biology, 3(4), 0692–0703.